In vivo studies with antisense oligonucleotides

[1] PHARMACOKINETICS, BIODISTRIBUTION, AND STABILITY OF OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATES IN MICE [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (17) : 7595 - 7599

[2] OLIGODEOXYNUCLEOSIDE PHOSPHORAMIDATES AND PHOSPHOROTHIOATES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (19) : 7079 - 7083

[3] Antisense oligonucleotides: Towards clinical trials [J]. TRENDS IN BIOTECHNOLOGY, 1996, 14 (10) : 376 - 387

[4] ABSORPTION, TISSUE DISTRIBUTION AND IN-VIVO STABILITY IN RATS OF A HYBRID ANTISENSE OLIGONUCLEOTIDE FOLLOWING ORAL-ADMINISTRATION [J]. BIOCHEMICAL PHARMACOLOGY, 1995, 50 (04) : 571 - 576

[5] PHARMACOKINETICS OF ANTISENSE OLIGONUCLEOTIDES [J]. CLINICAL PHARMACOKINETICS, 1995, 28 (01) : 7 - 16

[6] Novel enzymatic and immunological responses to oligonucleotides [J]. TOXICOLOGY LETTERS, 1995, 82-3 : 431 - 434

[7] Agrawal S., 1996, ANTISENSE THERAPEUTI

[8] STABILITY OF ANTISENSE DNA OLIGODEOXYNUCLEOTIDE ANALOGS IN CELLULAR-EXTRACTS AND SERA [J]. LIFE SCIENCES, 1991, 49 (24) : 1793 - 1801

[9] ATHTAR S, 1995, DELIVERY STRATEGIES

[10] IMMUNE STIMULATION BY AN ANTISENSE OLIGOMER COMPLEMENTARY TO THE REV GENE OF HIV-1 [J]. BIOCHEMICAL PHARMACOLOGY, 1993, 45 (10) : 2037 - 2043

[1] PHARMACOKINETICS, BIODISTRIBUTION, AND STABILITY OF OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATES IN MICE [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (17) : 7595 - 7599

[2] OLIGODEOXYNUCLEOSIDE PHOSPHORAMIDATES AND PHOSPHOROTHIOATES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (19) : 7079 - 7083

[3] Antisense oligonucleotides: Towards clinical trials [J]. TRENDS IN BIOTECHNOLOGY, 1996, 14 (10) : 376 - 387

[4] ABSORPTION, TISSUE DISTRIBUTION AND IN-VIVO STABILITY IN RATS OF A HYBRID ANTISENSE OLIGONUCLEOTIDE FOLLOWING ORAL-ADMINISTRATION [J]. BIOCHEMICAL PHARMACOLOGY, 1995, 50 (04) : 571 - 576

[5] PHARMACOKINETICS OF ANTISENSE OLIGONUCLEOTIDES [J]. CLINICAL PHARMACOKINETICS, 1995, 28 (01) : 7 - 16

[6] Novel enzymatic and immunological responses to oligonucleotides [J]. TOXICOLOGY LETTERS, 1995, 82-3 : 431 - 434

[7] Agrawal S., 1996, ANTISENSE THERAPEUTI

[8] STABILITY OF ANTISENSE DNA OLIGODEOXYNUCLEOTIDE ANALOGS IN CELLULAR-EXTRACTS AND SERA [J]. LIFE SCIENCES, 1991, 49 (24) : 1793 - 1801

[9] ATHTAR S, 1995, DELIVERY STRATEGIES

[10] IMMUNE STIMULATION BY AN ANTISENSE OLIGOMER COMPLEMENTARY TO THE REV GENE OF HIV-1 [J]. BIOCHEMICAL PHARMACOLOGY, 1993, 45 (10) : 2037 - 2043